164 related articles for article (PubMed ID: 30807775)
1. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
Calaway AC; Tachibana I; Masterson TA; Foster RS; Einhorn LH; Cary C
Urology; 2019 May; 127():74-79. PubMed ID: 30807775
[TBL] [Abstract][Full Text] [Related]
2. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
[TBL] [Abstract][Full Text] [Related]
3. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
[TBL] [Abstract][Full Text] [Related]
4. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.
Albqami N; Janetschek G
J Endourol; 2005; 19(6):683-92; discussion 692. PubMed ID: 16053357
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
Considine S; Heaney R; Conroy R; Thornhill JA
Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.
Silberstein JL; Bazzi WM; Vertosick E; Carver BS; Bosl GJ; Feldman DR; Bajorin DF; Motzer RJ; Al-Ahmadie H; Reuter VE; Sheinfeld J
J Urol; 2014 Aug; 192(2):415-9. PubMed ID: 24518791
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
10. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
12. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
[TBL] [Abstract][Full Text] [Related]
13. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
15. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors.
Rove KO; Maroni PD; Cost CR; Fairclough DL; Giannarini G; Harris AK; Schultz KA; Cost NG
Urology; 2016 Nov; 97():138-144. PubMed ID: 27538802
[TBL] [Abstract][Full Text] [Related]
16. Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy.
Shang B; Cao C; Jiang W; Shi H; Bi X; Cui C; Shou J; Zheng S; Zhang J; Zhou A; Li C; Ma J
Front Immunol; 2021; 12():720359. PubMed ID: 35082775
[TBL] [Abstract][Full Text] [Related]
17. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
18. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
[TBL] [Abstract][Full Text] [Related]
19. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
Spiess PE; Brown GA; Liu P; Tannir NM; Tu SM; Evans JG; Czerniak B; Kamat AM; Pisters LL
Cancer; 2006 Oct; 107(7):1483-90. PubMed ID: 16944541
[TBL] [Abstract][Full Text] [Related]
20. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
